
Home / Clinics Supported / Hormone Optimization / Men's Health & TRT
U.S. searches for “TRT near me” run 10,000 to 100,000 a month, and in many markets the nearest provider is a telehealth app. ACG helps you open the local clinic that builds the in-person relationship. No medical background is required to own the business; an independent, state-licensed Medical Director directs all clinical care.
Book a Strategy CallU.S. searches for “TRT near me” run 10,000 to 100,000 a month, and “online TRT” 1,000 to 10,000 (Google Keyword Planner). The demand is documented and steady.
The local clinic that earns a man's trust in January can still have him, and his referrals, in December.
In many markets the nearest TRT provider is a telehealth company, whose prescribing without an in-person exam rests on a DEA rule that runs through December 31, 2026. A local clinic with in-office labs builds the relationship an app cannot. ACG helps you open one through our launch program for independent clinics, without the lifetime royalties of a TRT franchise.
A patient whose labs are monitored by a provider who knows his baseline can stay enrolled for years. That relationship drives lifetime value in cash-pay men's health.
Google Keyword Planner, U.S., Sep 2025 to Aug 2026, in the ranges Google reports. Some testosterone terms return no figure. Local demand varies by market.
Testosterone therapy at the core, with the adjacent services that keep patients enrolled.
Injectable, pellet and topical protocols, prescribed and monitored by your Medical Director. The reason patients walk in.
Baseline and ongoing labs (metabolic panel, CBC, hormone panel), the visits that build the ongoing relationship.
Sermorelin, prescriber-directed, and PT-141 for sexual wellness (FDA-approved as Vyleesi only for premenopausal women, so off-label in men). CJC-1295 and ipamorelin, the two patients ask for by name, cannot be compounded today. See the peptide therapy status table.
ED treatment and PRP-based procedures that widen the menu without a separate clinic entity.
Metabolic panels, body composition tracking and FDA-approved GLP-1s for the TRT patient who needs them, as in a medical weight loss clinic.
Monthly protocol and lab memberships that create recurring revenue and keep patients engaged.
Testosterone is a Schedule III controlled substance, so DEA registration, prescribing structure and record-keeping must be in place, state by state, before the first patient.
Our team has navigated this across hundreds of launches: partner Medical Director networks cover all 50 states, and the compounding pharmacies are pre-vetted.
ACG sequences registration, prescribing structure and record-keeping for your state, with a plan for the December 31, 2026 telemedicine deadline.
Vetted MDs through partner networks in all 50 states who understand TRT clinic oversight requirements. ACG coordinates the supervision agreement.
Pre-vetted compounding pharmacy partners for testosterone and lawfully compoundable adjunct compounds at preferred pricing.
Patient intake, informed consent and clinical protocols, set with your Medical Director, in place before your first patient.
TRT advertising has specific platform restrictions. ACG plans a marketing strategy that fits them; execution is a separate engagement.
Straight answers on franchises, prescribers, telehealth, peptides and cost. Anything else, ask on the strategy call.
View All FAQs
The TRT clinic in your market is still waiting to be built. Talk with Grayson Miller about local demand, prescribing after 2026 and what opening takes. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary. The 60-day target begins from clinic keys received, market and regulatory conditions permitting.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.